Boston Neurosciences Overview
Latest Deal Type
Series A
Boston Neurosciences General Information
Description
Developer of medical device company designed to provide a suite of ultrasound-based devices. The company's devices offers non-invasive ICP measurement for conditions such as traumatic brain injury, concussion, hydrocephalus, stroke, brain tumors, and other neurological diseases, enabling clinicians to obtain safer, faster, accurate and cost-efficient measurements of absolute intracranial pressure values.
Want to dig into this profile?
We’ll help you find what you need
Learn more
Boston Neurosciences Valuation & Funding
| Deal Type |
Date |
Amount |
Raised to Date |
Post-Val |
Status |
Stage |
| 2. Early Stage VC (Series A) |
16-Oct-2015 |
$10M |
0000 |
0000 |
Completed |
Generating Revenue |
| 1. Grant |
|
0000 |
|
|
Completed |
Startup |
Boston Neurosciences Competitors (2)
| Company Name |
Financing Status |
Location |
Employees |
Total Raised |
Last Financing Date/Type |
Last Financing
Amount |
| Vortex Biosciences |
Venture Capital-Backed |
Pleasanton, CA |
|
|
000000&0 |
|
| 000000000 |
Venture Capital-Backed |
Toronto, Canada |
000 |
00000 |
0000000000 0 |
00000 |
Boston Neurosciences Executive Team (4)
| Name |
Title |
Board Seat |
Contact Info |
| T. Forcht Dagi MD |
Chief Executive Officer & Board Member |
|
|
3 Former Executives